4.6 Review

Intestinal Barrier Function in Health and Disease-Any Role of SARS-CoV-2?

Journal

MICROORGANISMS
Volume 8, Issue 11, Pages -

Publisher

MDPI
DOI: 10.3390/microorganisms8111744

Keywords

gastrointestinal; COVID-19; SARS-CoV-2; microbiota; gut barrier; gut permeability; gut-liver axis; immune; FMT; probiotics

Categories

Funding

  1. Foundation for Liver Research, London (UK)
  2. King's Undergraduate Research Fellowship (KURF) award, King's College London, London (UK)

Ask authors/readers for more resources

Alterations in the structure and function of the intestinal barrier play a role in the pathogenesis of a multitude of diseases. During the recent and ongoing coronavirus disease (COVID-19) pandemic, it has become clear that the gastrointestinal system and the gut barrier may be affected by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus, and disruption of barrier functions or intestinal microbial dysbiosis may have an impact on the progression and severity of this new disease. In this review, we aim to provide an overview of current evidence on the involvement of gut alterations in human disease including COVID-19, with a prospective outlook on supportive therapeutic strategies that may be investigated to rescue intestinal barrier functions and possibly facilitate clinical improvement in these patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available